Cannabix Technologies Inc. (BLOZF)
OTCMKTS · Delayed Price · Currency is USD
0.4270
+0.0544 (14.60%)
Nov 4, 2025, 4:00 PM EST
Cannabix Technologies Market Cap
Cannabix Technologies has a market cap or net worth of $51.59 million as of November 5, 2025. Its market cap has increased by 37.85% in one year.
Market Cap
51.59M
Enterprise Value
50.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.43
Market Cap Chart
Since December 18, 2013, Cannabix Technologies's market cap has increased from 540.03K to 51.59M, an increase of 9,452.66%. That is a compound annual growth rate of 46.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 51.59M | 101.45% |
| Dec 31, 2024 | 25.61M | 64.60% |
| Dec 29, 2023 | 15.56M | -43.24% |
| Dec 30, 2022 | 27.41M | -43.72% |
| Dec 31, 2021 | 48.71M | -34.40% |
| Dec 31, 2020 | 74.25M | 147.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 654.92M |
| Glass House Brands | 582.61M |
| Northwest Biotherapeutics | 386.96M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 311.61M |
| Silence Therapeutics | 307.49M |
| American Oncology Network | 307.04M |